Literature DB >> 1684795

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome.

A R Hauser1, D L Stevens, E L Kaplan, P M Schlievert.   

Abstract

Toxic shock-like syndrome (TSLS) is characterized by hypotension or shock, fever, multiorgan system involvement, and a concurrent group A streptococcal infection. We analyzed 34 streptococcal strains isolated from patients with clinically well-documented TSLS for their pyrogenic toxin profiles and M-protein types. Although strains of nine different M types were represented in the sample, 74% of the isolates were of either M type 1 or 3. It was determined that 53% produced streptococcal pyrogenic exotoxin type A under in vitro growth conditions and that 85% contained the gene encoding this toxin. These values are in contrast to the published value of 15% for the incidence of this gene in a sample of general group A streptococcal isolates. As has been found with all group A streptococci examined to date, regardless of disease association, 100% of TSLS-associated isolates contained the gene encoding pyrogenic exotoxin type B. This toxin was detectably produced by 59% of isolates. The gene encoding pyrogenic toxin type C was found in only 21% of isolates. We conclude that the pyrogenic exotoxin type A gene is associated with group A streptococcal strains isolated from patients with TSLS and may play a causative role in this illness. However, other factors are also likely to be important, since not all strains from patients with TSLS contained the A toxin gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684795      PMCID: PMC270163          DOI: 10.1128/jcm.29.8.1562-1567.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Group A streptococcal peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  S J Cavalieri; J M Allais; P M Schlievert; D L Dworzack; R B Clark
Journal:  Am J Med       Date:  1989-02       Impact factor: 4.965

2.  Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s.

Authors:  E L Kaplan; D R Johnson; P P Cleary
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness.

Authors:  P K Lee; P M Schlievert
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

4.  Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

Authors:  L A Cone; D R Woodard; P M Schlievert; G S Tomory
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

5.  Streptococcus pyogenes and the toxic shock syndrome.

Authors:  V Hríbalová
Journal:  Ann Intern Med       Date:  1988-05       Impact factor: 25.391

6.  Changing group A streptococci. The reappearance of streptococcal 'toxic shock'.

Authors:  G H Stollerman
Journal:  Arch Intern Med       Date:  1988-06

7.  Microtechnique for serum opacity factor characterization of group A streptococci adaptable to the use of human sera.

Authors:  D R Johnson; E L Kaplan
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

8.  'Toxic strep syndrome'. A manifestation of group A streptococcal infection.

Authors:  T Bartter; A Dascal; K Carroll; F J Curley
Journal:  Arch Intern Med       Date:  1988-06

9.  Changes in the pattern of infection caused by Streptococcus pyogenes.

Authors:  E Gaworzewska; G Colman
Journal:  Epidemiol Infect       Date:  1988-04       Impact factor: 2.451

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  58 in total

1.  Growth-phase-dependent expression of virulence factors in an M1T1 clinical isolate of Streptococcus pyogenes.

Authors:  M Unnikrishnan; J Cohen; S Sriskandan
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

Authors:  M Roggiani; J A Stoehr; S B Olmsted; Y V Matsuka; S Pillai; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  A comparison of group A streptococcal serotypes isolated from the upper respiratory tract in the USA and Thailand: implications.

Authors:  E L Kaplan; D R Johnson; P Nanthapisud; S Sirilertpanrana; S Chumdermpadetsuk
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

4.  Crystal structure of a dimeric form of streptococcal pyrogenic exotoxin A (SpeA1).

Authors:  Matthew D Baker; Inessa Gendlina; Carleen M Collins; K Ravi Acharya
Journal:  Protein Sci       Date:  2004-08-04       Impact factor: 6.725

5.  Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.

Authors:  Kim Ekelund; Jessica Darenberg; Anna Norrby-Teglund; Steen Hoffmann; Didi Bang; Peter Skinhøj; Helle Bossen Konradsen
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  Identification and characterization of bicistronic speB and prsA gene expression in the group A Streptococcus.

Authors:  Yongsheng Ma; Amy E Bryant; Dan B Salmi; Susan M Hayes-Schroer; Eric McIndoo; Michael J Aldape; Dennis L Stevens
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

7.  Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis.

Authors:  D Y Leung; J B Travers; R Giorno; D A Norris; R Skinner; J Aelion; L V Kazemi; M H Kim; A E Trumble; M Kotb
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Diagnosis of group A streptococcal necrotizing fasciitis by using PCR to amplify the streptococcal pyrogenic exotoxin B gene.

Authors:  L Louie; A E Simor; M Louie; A McGeer; D E Low
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A.

Authors:  J B Kline; C M Collins
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.